한글목차

뇌실외배액 세계 시장 규모는 2025년 69억 달러로 추정되며, 2032년에는 102억 4,000만 달러에 달할 것으로 예상되며, 2025년부터 2032년까지 CAGR 5.8%로 성장할 것으로 예측됩니다.

그림. 뇌실외배액 세계 시장 점유율(%), 지역별, 2025년

뇌실외배액(EVD)은 뇌척수액(CSF)의 일시적인 배출 및/또는 두개내압의 모니터링을 위해 측뇌실의 전각에 버홀을 통해 삽입하고 폐쇄형 무균 시스템에 연결되는 연성 카테터입니다. 뇌실외 배액의 적응증은 두개내압 상승 완화, 감염성 수액 우회, 뇌수술/출혈 후 혈흔 수액 우회, 수액 흐름 우회, 두개내압 모니터링 등입니다. 체외배액 및 모니터링은 뇌척수액을 체외로 배출하여 두개내압을 일시적으로 조절하는 표준 치료법입니다. 체외 배액 및 모니터링은 뇌척수액(CSF)을 뇌의 측뇌실 또는 척추의 요추강에서 체외 회수 백으로 일시적으로 배출하는 것을 말합니다. 뇌실외배액(EVD) 시스템은 중력과 뇌간 압력을 함께 사용하여 뇌척수액을 배출합니다. 배출 속도는 환자의 해부학적 구조에 대한 EVD 시스템의 설치 높이에 따라 달라집니다.

시장 역학:

연구 개발(R&D) 활동이 활발해짐에 따라 예측 기간 동안 세계 뇌실외배액 시장의 성장을 촉진할 것으로 예상됩니다. 예를 들어, 2024년 6월 스웨덴에 위치한 카롤린스카 대학병원은 '뇌실외배액 관련 감염을 확인하기 위한 새로운 진단법'이라는 제목의 임상시험을 시작했습니다. 이 치료는 뇌척수액 내 박테리아를 신속하고 직접적으로 검출하는 세 가지 새로운 진단법을 평가하고, 뇌척수액 박테리아 배양과 비교하여 신경계 중증 환자의 항생제 치료 지침으로 사용할 수 있는지 여부를 평가합니다. 이 조사는 2025년 12월 31일까지 완료될 예정입니다.

연구의 주요 특징

• 세계의 뇌실외배액 시장에 대해 조사 분석했으며, 2024년을 기준 연도로 하여 예측 기간(2025-2032년)의 시장 규모와 연평균 성장률(CAGR)에 대해 조사 분석하여 전해드립니다.
• 또한, 다양한 부문에 걸친 잠재적인 수익 성장 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
• 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 주요 인사이트를 제공합니다.
• 이 보고서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략 등의 매개 변수를 기반으로 세계 뇌실외배액 시장의 주요 기업 프로파일을 제공합니다.
• 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대, 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
• 이 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
• 이해관계자들은 세계 뇌실외배액 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.

목차

제1장 조사 목적과 가정

• 조사 목적
• 가정
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
  • 외상 발생률 증가
  • 수술 후 감염증 리스크
  • 아시아태평양의 신흥 시장
• 주요 하이라이트
• 최근 동향
• PEST 분석
• 최근의 제품 발매/승인
• 합병, 인수 및 제휴

제4장 세계의 뇌실외배액 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향

• COVID-19 역학
• 공급측과 수요측 분석
• 경제에 대한 영향

제5장 세계의 뇌실외배액 시장, 용도별, 2020-2032년

• 외상성 뇌손상
• 지주막하출혈
• 뇌내출혈
• 기타(비외상성 수두증)

제6장 세계의 뇌실외배액 시장, 환자 유형별, 2020-2032년

• 소아
• 성인

제7장 세계의 뇌실외배액 시장, 최종사용자별, 2020-2032년

• 병원
• 클리닉
• 외래 수술 센터
• 호스피스 케어 센터
• 기타

제8장 세계의 뇌실외배액 시장, 지역별, 2020-2032년

• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동
• 아프리카

제9장 경쟁 구도

• 기업 개요
  • Spiegelberg GmbH & Co. KG
  • Medtronic
  • Sophysa
  • Neuromedex GmbH
  • Integra LifeSciences
  • Moller Medical GmbH
  • Braun SE
  • Fuji Systems

제10장 섹션

• 참고문헌
• 조사 방법
• 출판사 소개

영문목차

Global External Ventricular Drain Market is estimated to be valued at USD 6.9 Bn in 2025 and is expected to reach USD 10.24 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.8% from 2025 to 2032.

Figure. Global External Ventricular Drain Market Share (%), By Region 2025

An external ventricular drain (EVD) is a soft catheter that is inserted via a burr hole into the anterior horn of the lateral ventricle and connected to a closed sterile system to allow for temporary drainage of cerebrospinal fluid (CSF) and/or monitoring of intracranial pressure. Indications for external ventricular drainage are: to relieve raised intracranial pressure, to divert infected CSF, to divert bloodstained CSF following neurosurgery/haemorrhage, to divert the flow of CSF, and to monitor intracranial pressure. External drainage and monitoring is the standard of care for temporarily controlling intracranial pressure by draining cerebrospinal fluid externally from the body. External drainage and monitoring is the temporary drainage of cerebrospinal fluid (CSF) from the lateral ventricles of the brain, or the lumbar space of the spine, into an external collection bag. An external ventricular drainage (EVD) system drains CSF by using a combination of gravity and intercerebral pressure. The drainage rate depends on the height at which the EVD system is placed relative to the patient's anatomy.

Market Dynamics:

Increasing research and development (R&D) activities is expected to drive the growth of the global external ventricular drain market over the forecast period. For instance, in June 2024, Karolinska University Hospital, a hospital based in Sweden, initiated a clinical trial titled "Novel Diagnostic Methods to Identify External Ventricular Drain Associated Infections". This study will evaluate three novel diagnostic methods for rapid direct bacterial detection in CSF, in order to assess, if these can be used to guide antibiotic treatment in neurocritically ill patients, as compared to CSF bacterial cultures. The study is expected to get completed by December 31, 2025.

Key Features of the Study:

• This report provides an in-depth analysis of the global external ventricular drain market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global external ventricular drain market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Spiegelberg GmbH & Co. KG, Medtronic, Sophysa, Neuromedex GmbH, Integra LifeSciences, Moller Medical GmbH, B. Braun SE and Fuji Systems
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global external ventricular drain market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global external ventricular drain market

Detailed Segmentation:

• Global External Ventricular Drain Market, By Application
  • Traumatic Brain Injury
  • Subarachnoid Hemorrhage
  • Intracerebral Hemorrhage
  • Other (Non-traumatic Hydrocephalus Condition)
• Global External Ventricular Drain Market, By Patient Type
  • Pediatric
  • Adult
• Global External Ventricular Drain Market, By End User
  • Hospitals
  • Clinics
  • Ambulatory Surgery Centers
  • Others
• Global External Ventricular Drain Market, By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
• Company Profiles
  • Spiegelberg GmbH & Co. KG
  • Medtronic
  • Sophysa
  • Neuromedex GmbH
  • Integra LifeSciences
  • Moller Medical GmbH
  • Braun SE
  • Fuji Systems

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Application
  • Market Snippet, By Patient Type
  • Market Snippet, By End User
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Increasing prevalence of traumatic injuries
  • Risk of post-surgery infections
  • Emerging markets in the Asia Pacific region
• Key Highlights
• Recent Trends
• PEST Analysis
• Recent Product Lauches/Approvals
• Mergers, Acquisitions, and Collaborations

4. Global External Ventricular Drain Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global External Ventricular Drain Market, By Application, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Traumatic Brain Injury
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Subarachnoid Hemorrhage
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Intracerebral Hemorrhage
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Other ((Non-traumatic Hydrocephalus Condition)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global External Ventricular Drain Market, By Patient Type, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Pediatric
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Adult
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global External Ventricular Drain Market, By End User, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Ambulatory Surgical Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Hospice Care Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Global External Ventricular Drain Market, By Region, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021 - 2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profile
  • Spiegelberg GmbH & Co. KG
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Medtronic
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Sophysa
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Neuromedex GmbH
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Integra LifeSciences
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Moller Medical GmbH
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Braun SE
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Fuji Systems
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Analyst Views

10. Section

• References
• Research Methodology
• About us